Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Weekly injection shows promise for Long-Term HIV control

NCT ID NCT05271370

Summary

This study tested whether people with well-controlled HIV could continue using weekly PRO140 injections alone to maintain viral suppression long-term. The research followed 56 participants who had already completed 48 weeks of treatment in a previous study. The main goals were to check long-term safety and see how well the weekly injections kept HIV levels undetectable without other medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Quest Clinical Research

    San Francisco, California, 94115, United States

Conditions

Explore the condition pages connected to this study.